Why Valeant Pharmaceuticals Intl Inc. Shares Surged as Much as 17% on Monday

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shares soared after the company announced Michael Pearson will be stepping down.

| More on:
The Motley Fool

On March 21, there were more developments in the Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) saga.

Most notably, the company announced that CEO Michael Pearson will be stepping down as soon as a successor is found. In addition, activist investor Bill Ackman, head of Pershing Square Capital Management, has now joined the board of directors. And to top it all off, Valeant blamed its past financial misstatements on former CFO Howard Schiller and asked him to resign from the board of directors. Yet he has refused to do so.

While these developments may look like signs of chaos, investors reacted warmly to the news, sending Valeant’s shares up by as much as 17%. So why exactly did Valeant’s shares increase, and what does this news mean for the company in the long term?

Michael Pearson’s departure

Michael Pearson has been the face of Valeant’s rise as well as its fall. It was he who moved the company from the United States to Canada primarily for tax reasons. It was he who slashed Valeant’s R&D spending in favour of an acquisition-based model. And as the company finds itself in a downward spiral, he is at the centre of it all.

Up until March he was still held in very high regard. When the Philidor story dominated headlines, Mr. Ackman reiterated his support for Mr. Pearson. Then when Mr. Pearson had to step down at the end of 2015 (for health-related reasons), Valeant’s share price fell. More recently, Nomura Securities analyst Shibani Malhotra said Valeant would lose its competitive advantage if Mr. Pearson stepped down.

But that all changed when Valeant lowered its 2016 guidance on March 14. Now there’s a sense that the company has no idea what it’s doing, which, of course, reflects badly on the CEO. So it’s no surprise that his departure is being received well.

Bill Ackman’s presence

Not unlike Mr. Pearson, Bill Ackman is another public figure whose reputation has taken a dramatic turn for the worse.

Long known as one of Wall Street’s best activist investors, Mr. Ackman has had some remarkable successes; for example, he initiated the turnaround at Canadian Pacific Railway Limited, which has been a tremendous win for shareholders of that company.

But more recently, the story has been very different. When Valeant started running into trouble, he increased his stake, saying his biggest regret was that he wasn’t in a position to buy more shares. He also said that the company’s biggest problem was poor communication. During a conference call, he even predicted that Valeant’s shares would reach US$448 by 2019.

Yet Mr. Ackman still is held in high regard, so his decision to join the board may be viewed as a small positive.

Howard Schiller

It may seem unfair that Mr. Schiller is being made the scapegoat, since he stepped in as interim-CEO during a very difficult time. Then again, he was CFO at a time when the company misstated its financials.

In any case, this controversy is really more of a side story. Mr. Pearson’s departure was certainly the main reason Valeant’s share price increased, and Mr. Ackman’s increased involvement was likely a factor as well. We’ll have to wait and see how this all plays out.

Fool contributor Benjamin Sinclair has no position in any stocks mentioned.  Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

top TSX stocks to buy
Stocks for Beginners

How to Turn a $15,000 TFSA Into $150,000

Here's how you can optimize your TFSA to ensure your capital is generating the highest returns possible without taking on…

Read more »

An investor uses a tablet
Investing

TD vs. Royal Bank: Which Stock Offers Investors More for 2026?

Investors looking to decide between Royal Bank of Canada (TSX:RY) and Toronto-Dominion Bank (TSX:TD) should consider these key factors.

Read more »

A worker drinks out of a mug in an office.
Dividend Stocks

Beyond Telus: These Dividend Heavyweights Look Like Better Buys Today

Bank of Nova Scotia (TSX:BNS) stock might be a safer, steadier bet than the higher-yielding telecom titans.

Read more »

four people hold happy emoji masks
Dividend Stocks

My Favourite Dividend Stocks for Canadians to Buy in 2026

Make 2026 your year for investing in stocks. Find out how to create a profitable investment strategy for optimal returns.

Read more »

a person watches stock market trades
Stocks for Beginners

Invest in This TSX Stock Today for More Wealth Tomorrow

Dollarama rarely looks cheap, but its steady “trade-down” demand and relentless execution have made it one of the TSX’s best…

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Wednesday, December 31

Despite recent softness, the TSX remains on track to finish 2025 with nearly 29% gains, with today’s session expected to…

Read more »

A worker drinks out of a mug in an office.
Investing

Where Will Dollarama Stock Be in 3 Years?

Here's how high Dollarama stock could climb over the next three years, and whether it's worth buying in the current…

Read more »

3 colorful arrows racing straight up on a black background.
Stocks for Beginners

3 Monster Stocks to Hold for the Next 3 Years

These three Canadian stocks combine real growth drivers with the kind of execution long-term investors look for.

Read more »